ReproCyc PRRS EU inj. susp. (lyoph.) i.m. vial

Kraj: Belgia

Język: angielski

Źródło: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Składnik aktywny:

Porcine Reproductive and Respiratory Syndrome Virus (Live, Attenuated)

Dostępny od:

Boehringer Ingelheim Vetmedica GmbH

Kod ATC:

QI09AD03

INN (International Nazwa):

Porcine Respiratory and Reproductive Syndrome Virus (PRRSV), Live, Attenuated

Forma farmaceutyczna:

Lyophilisate and solvent for suspension for injection

Skład:

Porcine Respiratory and Reproductive Syndrome Virus (PRRSV), Live, Attenuated

Droga podania:

Intramuscular use

Grupa terapeutyczna:

pig

Dziedzina terapeutyczna:

Porcine Reproductive and Respiratory Syndrome (PRRS) Virus

Podsumowanie produktu:

CTI code: 474880-06 - Pack size: 25 x 100 doses (200 (200) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-04 - Pack size: 25 x 10 doses (20 (20) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-05 - Pack size: 25 x 50 doses (100 (100) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-02 - Pack size: 12 x 50 doses (100 (100) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-03 - Pack size: 12 x 100 doses (200 (200) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-01 - Pack size: 12 x 10 doses (20 (20) - Commercialisation status: NO - Delivery mode: Medical prescription

Status autoryzacji:

Commercialised: No

Data autoryzacji:

2015-06-16